Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Vital Farms, Inc. VITL

Consumer Defensive — Farm Products
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total buys
0.61
Total sells
5.05
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — 2 — 11 — — — —
Sell 1 1 3 1 1 2 — — — — — —
Insider Ownership
18.11%

Capital & Financial Ratios

Market Cap
504.78
Revenue
765.67
Net Income
0.16
Free Cash Flow
(124.87)
Net Debt
10.86
Current Ratio
1.10
Debt/Equity
0.11
P/E ratio
0.00
P/S ratio
0.67
P/B ratio
1.81
Past 5Y EPS Growth
81.00%
This Y EPS Growth
(134.38%)
Next Y EPS Growth
163.64%
Next 5Y EPS Growth
(21.37%)
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
—
Annual Dividend Yield
—
total individual payouts
2025 ‡‡‡
2024 ‡‡‡
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
2020 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 116.82 160.29 113.35 21.24
Receivables 39.70 54.34 69.26 52.14
Inventory 32.90 23.67 66.50 73.89
Other — — 2.14 2.14
195.52 246.04 262.55 162.89
2023 2024 2025 Q'26
Payables 33.49 38.58 55.14 56.21
ST’ Debt — — — —
Other — — — —
65.22 78.53 121.58 147.58
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow — ‡‡‡‡‡ ‡‡‡
Earnings — ‡‡‡‡‡ ‡‡‡‡‡
Book Value — ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 187.16 166.03 — —
—
’25 162.19 184.77 198.94 213.55
759.44
’24 147.93 147.39 145.00 165.99
606.31
’23 119.17 106.45 110.43 135.81
471.86
’22 77.06 82.87 92.04 110.08
362.05
’21 58.55 60.32 64.63 77.41
260.90
’20 47.58 59.34 53.37 53.99
214.28
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (18.55) (27.36) — —
—
’25 5.27 (0.76) 23.42 5.78
33.72
’24 23.95 16.13 9.96 14.78
64.82
’23 5.40 13.51 8.27 23.73
50.91
’22 (4.94) 1.93 (0.36) (4.73)
(8.10)
’21 8.04 7.63 (2.36) 4.38
17.68
’20 0.85 16.88 (2.68) (3.53)
11.51
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (39.31) (43.94) — —
—
’25 2.20 (7.07) (10.19) (31.43)
(46.49)
’24 22.63 10.54 6.39 (3.38)
36.18
’23 4.66 11.02 3.42 21.33
40.42
’22 (6.57) (0.80) (2.80) (8.29)
(18.47)
’21 4.59 3.27 (8.74) 1.86
0.97
’20 (3.42) 15.76 (4.02) (7.10)
1.21
in millions of $

EPS

Mar Jun Sep Dec Year
’26 (0.03) (0.72) — —
—
’25 0.37 0.36 0.36 0.35
1.44
’24 0.43 0.36 0.16 0.23
1.18
’23 0.16 0.15 0.10 0.17
0.59
’22 (0.04) 0.00 0.02 0.04
0.03
’21 0.08 0.09 (0.03) (0.09)
0.06
’20 0.05 0.16 0.04 (0.02)
0.27

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

2.2
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — ‡‡‡‡‡ ‡‡‡‡‡ 7.89 10.23 14.16 28.87 — — —
Low Price
— — — — ‡‡‡‡ ‡‡‡‡‡ 19.38 18.18 48.41 53.13 — — —
High Price
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 368 447 598 739 — — —
Employees
— ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.98 1.06 1.01 1.03 — — —
Revenue/Emp
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 362.05 471.86 606.31 759.44 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 30.23% 34.40% 37.92% 37.62% — — —
Gross Margin
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.83 32.20 67.54 91.26 ‡‡‡‡‡ — —
EBT
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.78% 6.82% 11.14% 12.02% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
— ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.23 25.57 53.39 66.28 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7.99 8.27 13.26 13.33 — — —
Depreciation
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.91 11.45 14.15 17.03 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
— ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 0.03 0.62 1.25 1.49 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Earnings/Sh
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.20) 1.24 1.51 0.76 — — —
Cash Flow/Sh
— ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.26) (0.25) (0.67) (1.80) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.45) 0.98 0.84 (1.04) — — —
Free CF/Sh
— ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.90 4.68 6.28 7.88 ‡‡‡‡ — —
Book Value/Sh
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 40.65 41.19 42.85 44.59 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 504.67 24.89 30.15 21.58 ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.70 1.35 2.66 1.88 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.89 3.30 6.00 4.05 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.51 1.13 2.42 1.74 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (29.59) 13.19 40.54 (28.39) — — —
EV/FCF
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (8.10) 50.91 64.82 33.72 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (10.37) (10.48) (28.64) (80.21) ‡‡‡‡‡ — —
Capex
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (18.47) 40.42 36.18 (46.49) ‡‡‡‡‡ — —
FCF
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 101.96 130.30 167.51 140.97 — — —
Working Cap'
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.80 10.48 8.01 5.10 — — —
Total Debt
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (68.93) (106.33) (152.28) (108.25) — — —
Net Debt
— — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 158.33 192.68 269.30 351.26 — — —
Sh' Equity
— ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.62% 10.44% 16.83% 15.10% ‡‡‡‡‡ — —
ROA
— — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.47% 24.07% 33.94% 22.73% — — —
ROIC
— ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.81% 14.57% 23.11% 21.36% ‡‡‡‡‡ — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Vital Farms (VITL) has evolved from a niche Texas egg producer into a national powerhouse of premium, pasture-raised products, capitalizing on consumer demand for ethical farming with revenue surging 183% from $214 million in 2020 to $606 million in 2024 (32% CAGR). Gross margins expanded to 37.9%, profitability flipped to robust levels with EBT at $67.5 million (11.1% margin), EPS doubling to $1.25, and FCF per share hitting $0.84 amid efficient capex scaling. Analysts forecast continued momentum: $1.14 billion revenue by 2027 (21% YoY growth) and EPS over $2, backed by vertical integration, butter category gains, and a cash-rich balance sheet with elite 33.9% ROIC.

Despite this fundamental rocket ship, the stock has whipsawed, retreating 40-50% from 2024 highs to trade at compelling valuations—forward PE of 13-19x, EV/Sales projected to 0.96x by 2027—suggesting a disconnect ripe for rerating. Wall Street agrees, with targets implying 55-110% upside, fueled by structural demand in the $12 billion egg market where premiums command 2-3x pricing power.

Insider selling ($41 million over the past year, no buys) raises eyebrows amid heavy capex, potentially signaling profit-taking post-run-up rather than distress, while risks like avian flu and competition loom. Yet, with cultural tailwinds and execution, Vital Farms could revisit highs and beyond—read the full analysis for the data-backed case on this undervalued growth gem.

Read full commentary →

Vital Farms, Inc. (VITL) Latest News

News by impact score

Fine-tune

17 Sep

4 www.proactiveinvestors.com, 12:50 PM
Vital Farms shares rally as investors weigh possible sale of the company. Possible sale speculation signals major strategic shifts that could reshape Vital Farms' trajectory and market valuation.

13 Aug

3 transcript www.fool.com, 7:57 AM
Vital Farms held its Q2 2026 earnings call covering quarterly financial results, operational updates, and management outlook on growth and margins. Quarterly earnings calls deliver performance metrics and guidance that can shift near-term investor views without guaranteeing structural change.

7 Aug

3 transcript www.marketbeat.com, 3:04 PM
Vital Farms Q2 revenue rose with higher egg and butter sales; executives highlighted distribution gains, pasture-raised demand, and raised full-year guidance during the earnings call. Quarterly results and guidance updates typically produce moderate shifts in near-term sentiment and valuation without altering long-term strategy.

6 Aug

4 , 9:00 AM
Silver Point leads $125 million term loan financing for Vital Farms. $125 million term loan delivers major capital infusion that strengthens Vital Farms balance sheet and growth capacity.

4 , 7:44 AM
Vital Farms exceeded Q2 CY2026 sales expectations and issued optimistic full-year sales guidance. Q2 sales beat combined with raised full-year guidance signals stronger revenue trajectory and positive investor sentiment for Vital Farms.

3 , 7:00 AM
Vital Farms reported its second quarter 2026 financial results. Quarterly earnings releases typically produce moderate short-term effects on stock price and sentiment.

24 Jul

3 , 5:21 AM
Vital Farms is presented as the standout momentum stock with exciting potential among three analyzed, with the other two dismissed. Positive coverage of Vital Farms as a high-potential momentum stock may enhance market sentiment and attract investor attention.

24 Jun

3 Insider Monkey, 10:29 AM
Vital Farms (VITL) faced multiple pressures in Q1 that weighed on performance and market results. Q1 pressures point to operational and financial headwinds likely to affect near-term results and investor views.

19 Jun

3 , 8:40 AM
Competitive pressures impacted Vital Farms' Q1 performance and results. Competitive pressure in Q1 directly affects financial performance and market position.

3 Jun

4 , 5:19 PM
Vital Farms cuts guidance and refocuses on eggs, resetting investor expectations for future performance. Guidance cut combined with core product refocus signals major strategic shift likely to alter company trajectory and sentiment.

1 Jun

4 transcript www.fool.com, 4:49 PM
Vital Farms (VITL) released its Q1 2026 earnings call transcript covering financial results, operational updates, and forward outlook. Q1 earnings figures and management guidance directly shape near-term valuation and investor sentiment for VITL.

22 May

3 Insider Monkey, 8:35 AM
Vital Farms missed Q1 earnings targets yet posted revenue growth and margin resilience that point to operational stability and continued expansion potential. Q1 shortfall is offset by revenue and margin strength that keeps overall trajectory largely intact.

14 May

4 Simply Wall St., 4:12 AM
Vital Farms faces lawsuits as its exit from the butter market refocuses scrutiny on its core egg business. Lawsuits combined with butter exit signal major legal and strategic risks impacting financials and investor sentiment.

11 May

3 Zacks, 12:35 PM
Vital Farms, Inc. (VITL) recorded a Q1 loss, with gross profit declining due to higher costs. Q1 loss and gross profit decline from higher costs will moderately impact financial performance and investor sentiment.

9 May

4 www.marketbeat.com, 3:10 AM
Vital Farms reported Q1 revenue of $147.4 million, up 36% YoY, net income of $19.3 million or $0.38 per diluted share, gross margin expansion to 44.3%, and raised full-year revenue guidance to $740-760 million with EPS outlook of $1.25-1.40. Strong Q1 beats, margin gains, and upward guidance revisions indicate significant positive momentum for future growth and investor confidence.

8 May

4 www.barchart.com, 12:11 PM
Vital Farms (VITL) stock plunged 25% after Q1 earnings revealed weaker revenue growth, margin compression, and guidance below expectations, sparking investor sell-off. 25% stock drop post-Q1 earnings highlights significant short-term pressure on valuation and future performance expectations.

7 May

4 StockStory, 7:45 AM
Vital Farms reported better-than-expected sales for Q1 CY2026, but its stock plunged 24.2%. Beating sales expectations yet suffering a 24.2% stock drop highlights significant investor unease likely impacting short-term performance and sentiment.

4 Business Wire, 7:00 AM
Vital Farms, Inc. (VITL) reported first quarter 2026 financial results. Quarterly earnings reports directly impact financial performance, investor sentiment, and stock trajectory.

3 Zacks, 8:50 AM
Vital Farms (VITL) reported a Q1 net loss but exceeded revenue estimates. Q1 loss despite revenue beat impacts short-term financial perception and stock sentiment without fundamentally changing trajectory.

3 May

3 Simply Wall St., 1:10 AM
Vital Farms (VITL) valuation faces investor scrutiny amid ERP implementation lawsuits and intensified brand marketing efforts. ERP lawsuits risk operational disruptions and costs, offset somewhat by brand initiatives enhancing market perception.

30 Apr

3 Zacks, 10:00 AM
Analysts forecast Vital Farms (VITL) to report declining earnings, highlighting key metrics and factors for investors to monitor ahead of the release. Expected earnings decline targets core financial performance, likely influencing investor sentiment and stock price moderately.

27 Apr

3 Zacks, 9:30 AM
Wall Street analysts maintain bullish views on Vital Farms (VITL), prompting evaluation of its investment potential amid positive outlooks. Wall Street's bullish views signal moderately noticeable positive influence on investor sentiment and VITL's market performance.

25 Apr

4 Simply Wall St., 2:04 AM
Analysts are resetting expectations for Vital Farms (VITL), shifting its investment story amid slowing growth, margin pressures, and competitive challenges in the egg market. Analyst expectation resets signal significant shifts in Vital Farms' growth trajectory and investor sentiment.

10 Apr

4 Simply Wall St., 7:12 AM
Vital Farms, Inc. (VITL) faces ERP implementation lawsuits and disclosure questions that could undermine its investment appeal. ERP lawsuits and disclosure issues threaten significant operational disruptions and erosion of investor confidence.

9 Apr

4 Simply Wall St., 6:09 AM
Vital Farms (VITL) valuation faces scrutiny after lawsuits and analyst downgrades, raising concerns over future performance and stock price amid operational challenges. Lawsuits introduce legal and financial risks, while analyst downgrades signal weakened market sentiment, likely significantly impacting VITL's trajectory and investor confidence.

24 Mar

4 Simply Wall St., 2:05 AM
Vital Farms (VITL) cut guidance, sparking mixed analyst views and shifting its investment narrative amid concerns over growth and performance. Guidance cuts directly challenge VITL's financial outlook and investor confidence, potentially altering stock trajectory.

23 Mar

3 StockStory, 5:39 PM
Vital Farms (VITL) stock draws attention for two key positive reasons while urging caution on one risk factor. Two catalysts for optimism offset by one caution signal moderate effects on financial outlook and sentiment.

13 Mar

4 Simply Wall St., 12:10 PM
Vital Farms (VITL) faces valuation pressure after reporting weak earnings and amid rising legal scrutiny from ongoing investigations. Weak earnings directly hit financials while legal scrutiny introduces substantial risks to operations and investor sentiment.

9 Mar

4 Simply Wall St., 8:11 AM
Vital Farms (VITL) is reworking growth targets and margins, shifting its overall story and future outlook. Reworking growth targets and margins signals major strategic adjustments that could significantly alter VITL's trajectory and investor sentiment.

2 Mar

4 Simply Wall St., 7:21 PM
Vital Farms (VITL) shares plunged 21.3% after the company cut its 2026 outlook and announced a leadership shift, sparking debate on whether the bull case remains intact. Cutting the 2026 outlook and leadership changes caused a sharp 21.3% stock drop, indicating substantial risks to growth trajectory and investor confidence.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us